Drug misuse and abuse on the rise in the US
UK NICE issues guidance on lung cancer therapies
News in brief ...
Aromatase inhibitors of value in breast cancer treatment
Debating the cost effectiveness of zanamivir vs oseltamivir
'Surprising' results of HIV-related spending trend discussed
Growth in disease management outsourcing revenues
Nasal calcitonin vs etidronic, alendronic acid worth it in Canada?
Evidence that COPD management worth the risk
ADHD: physician specialty predicts diagnosis/treatment
News in brief ...
Annual bill for herpes zoster £50m in England and Wales
New acellular pertussis vaccine superior in Ontario, Canada
No change in drug utilisation with cost-sharing insurance
Patients' attitudes regarding benzodiazepine use important
Statins for cholesterol reduction - who should be treated?
News in brief ...
News in brief ...
News in brief ...
β2-Agonists: consensus guidelines not followed in asthma
Warfarin underused in elderly women with AF
Clozapine, haloperidol treatment response and QOL in schizophrenia
News in brief ...
Growth in US drug spending slows
GlaxoSmithKline extends preferential pricing
News in brief ...
Pharmaceutical industry concern over Welsh proposals